Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene

Biotechnology company Amgen (NasdaqGS: AMGN) is throwing $2.7 billion into BeiGene (NasdaqGS: BGNE), sending the Chinese biotech’s shares surging and bolstering sector-related ETFs. Among the top performers on Friday, the Loncar Cancer Immunotheraphy ETF (NasdaqGM: CNCR) increased 3.2% and...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.